ALCON INC (2U3.DE) Stock Fundamental Analysis
Europe - FRA:2U3 - CH0432492467 - Common Stock
65.48 EUR
+1.42 (+2.22%)
Taking everything into account, 2U3 scores 5 out of 10 in our fundamental rating. 2U3 was compared to 60 industry peers in the Health Care Equipment & Supplies industry. 2U3 has only an average score on both its financial health and profitability. 2U3 has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
2U3 had positive earnings in the past year.
2U3 had a positive operating cash flow in the past year.
2U3 had positive earnings in 4 of the past 5 years.
2U3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of 2U3 (3.61%) is comparable to the rest of the industry.
2U3 has a Return On Equity (5.09%) which is in line with its industry peers.
With a Return On Invested Capital value of 3.93%, 2U3 is not doing good in the industry: 61.67% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for 2U3 is significantly below the industry average of 9.00%.
The last Return On Invested Capital (3.93%) for 2U3 is above the 3 year average (3.01%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.61% | ||
| ROE | 5.09% | ||
| ROIC | 3.93% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
1.3 Margins
2U3 has a better Profit Margin (11.28%) than 71.67% of its industry peers.
2U3's Profit Margin has improved in the last couple of years.
2U3's Operating Margin of 14.07% is fine compared to the rest of the industry. 2U3 outperforms 71.67% of its industry peers.
In the last couple of years the Operating Margin of 2U3 has grown nicely.
With a Gross Margin value of 54.25%, 2U3 perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
2U3's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.07% | ||
| PM (TTM) | 11.28% | ||
| GM | 54.25% |
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2U3 is destroying value.
Compared to 1 year ago, 2U3 has more shares outstanding
2U3 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 2U3 has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.17 indicates that 2U3 is not in any danger for bankruptcy at the moment.
The Altman-Z score of 2U3 (4.17) is better than 75.00% of its industry peers.
The Debt to FCF ratio of 2U3 is 3.58, which is a good value as it means it would take 2U3, 3.58 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 2U3 (3.58) is better than 73.33% of its industry peers.
2U3 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
2U3 has a Debt to Equity ratio of 0.23. This is in the better half of the industry: 2U3 outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.58 | ||
| Altman-Z | 4.17 |
ROIC/WACC0.83
WACC4.73%
2.3 Liquidity
A Current Ratio of 2.70 indicates that 2U3 has no problem at all paying its short term obligations.
The Current ratio of 2U3 (2.70) is better than 78.33% of its industry peers.
2U3 has a Quick Ratio of 1.66. This is a normal value and indicates that 2U3 is financially healthy and should not expect problems in meeting its short term obligations.
2U3 has a better Quick ratio (1.66) than 76.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.7 | ||
| Quick Ratio | 1.66 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.23% over the past year.
Measured over the past years, 2U3 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.04% on average per year.
Looking at the last year, 2U3 shows a small growth in Revenue. The Revenue has grown by 4.82% in the last year.
Measured over the past years, 2U3 shows a small growth in Revenue. The Revenue has been growing by 5.71% on average per year.
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
3.2 Future
Based on estimates for the next years, 2U3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.63% on average per year.
2U3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y1.29%
EPS Next 2Y7.54%
EPS Next 3Y10.27%
EPS Next 5Y11.63%
Revenue Next Year5.35%
Revenue Next 2Y6.52%
Revenue Next 3Y6.66%
Revenue Next 5Y6.3%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 25.48, 2U3 can be considered very expensive at the moment.
71.67% of the companies in the same industry are more expensive than 2U3, based on the Price/Earnings ratio.
2U3's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.86.
A Price/Forward Earnings ratio of 21.78 indicates a rather expensive valuation of 2U3.
61.67% of the companies in the same industry are more expensive than 2U3, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of 2U3 to the average of the S&P500 Index (23.32), we can say 2U3 is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.48 | ||
| Fwd PE | 21.78 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 2U3 indicates a somewhat cheap valuation: 2U3 is cheaper than 61.67% of the companies listed in the same industry.
2U3's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 2U3 is cheaper than 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.42 | ||
| EV/EBITDA | 15.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2U3 does not grow enough to justify the current Price/Earnings ratio.
2U3 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)19.73
PEG (5Y)2.54
EPS Next 2Y7.54%
EPS Next 3Y10.27%
5. Dividend
5.1 Amount
2U3 has a yearly dividend return of 0.47%, which is pretty low.
2U3's Dividend Yield is comparable with the industry average which is at 2.13.
With a Dividend Yield of 0.47, 2U3 pays less dividend than the S&P500 average, which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.47% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
2U3 pays out 11.61% of its income as dividend. This is a sustainable payout ratio.
DP11.61%
EPS Next 2Y7.54%
EPS Next 3Y10.27%
FRA:2U3 (10/3/2025, 7:00:00 PM)
65.48
+1.42 (+2.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners69.85%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap32.72B
Analysts80
Price Target92.52 (41.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.47% |
Yearly Dividend0.22
Dividend Growth(5Y)N/A
DP11.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.84%
Min EPS beat(2)-4.26%
Max EPS beat(2)0.57%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-4.26%
Max EPS beat(4)7.68%
EPS beat(8)6
Avg EPS beat(8)1.96%
EPS beat(12)8
Avg EPS beat(12)2.89%
EPS beat(16)12
Avg EPS beat(16)5.61%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-3.43%
Max Revenue beat(2)-0.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-0.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.32%
Revenue beat(12)2
Avg Revenue beat(12)-0.76%
Revenue beat(16)6
Avg Revenue beat(16)0.43%
PT rev (1m)-4.17%
PT rev (3m)-4.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)-0.61%
EPS NY rev (3m)-6.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.57%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.48 | ||
| Fwd PE | 21.78 | ||
| P/S | 3.87 | ||
| P/FCF | 26.42 | ||
| P/OCF | 18.11 | ||
| P/B | 1.74 | ||
| P/tB | 11.15 | ||
| EV/EBITDA | 15.99 |
EPS(TTM)2.57
EY3.92%
EPS(NY)3.01
Fwd EY4.59%
FCF(TTM)2.48
FCFY3.78%
OCF(TTM)3.62
OCFY5.52%
SpS16.93
BVpS37.53
TBVpS5.87
PEG (NY)19.73
PEG (5Y)2.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.61% | ||
| ROE | 5.09% | ||
| ROCE | 4.85% | ||
| ROIC | 3.93% | ||
| ROICexc | 4.14% | ||
| ROICexgc | 12.86% | ||
| OM | 14.07% | ||
| PM (TTM) | 11.28% | ||
| GM | 54.25% | ||
| FCFM | 14.64% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
ROICexc(3y)3.18%
ROICexc(5y)N/A
ROICexgc(3y)10.24%
ROICexgc(5y)N/A
ROCE(3y)3.72%
ROCE(5y)N/A
ROICexcg growth 3Y2.95%
ROICexcg growth 5Y30.08%
ROICexc growth 3Y10.31%
ROICexc growth 5Y41.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.58 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 53.75% | ||
| Cap/Sales | 6.72% | ||
| Interest Coverage | 7.59 | ||
| Cash Conversion | 80.39% | ||
| Profit Quality | 129.73% | ||
| Current Ratio | 2.7 | ||
| Quick Ratio | 1.66 | ||
| Altman-Z | 4.17 |
F-Score6
WACC4.73%
ROIC/WACC0.83
Cap/Depr(3y)77.98%
Cap/Depr(5y)73.14%
Cap/Sales(3y)9.96%
Cap/Sales(5y)10.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
EPS Next Y1.29%
EPS Next 2Y7.54%
EPS Next 3Y10.27%
EPS Next 5Y11.63%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
Revenue Next Year5.35%
Revenue Next 2Y6.52%
Revenue Next 3Y6.66%
Revenue Next 5Y6.3%
EBIT growth 1Y12.13%
EBIT growth 3Y13.34%
EBIT growth 5Y43.18%
EBIT Next Year35.35%
EBIT Next 3Y18.66%
EBIT Next 5Y15.03%
FCF growth 1Y202.71%
FCF growth 3Y104.3%
FCF growth 5Y41.96%
OCF growth 1Y71.52%
OCF growth 3Y15.59%
OCF growth 5Y17.69%